Jain Global’s DexCom DXCM Stock Holding History

Jain Global’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-59,875	Closed	-$3.76M	–	1817
2026 Q1	$3.76M	Buy	+59,875	New	+$4.17M	0.02%	545
2025 Q3	–	Sell	-3,066	Closed	-$268K	–	1142
2025 Q2	$268K	Buy	+3,066	New	+$240K	﹤0.01%	917
2025 Q1	–	Sell	-43,280	Closed	-$3.37M	–	1141
2024 Q4	$3.37M	Buy	+43,280	New	+$3.2M	0.1%	175

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jain Global's DXCM Position: Q2 2026 in Review

Jain Global sold out of DexCom (DXCM) in Q2 2026, closing a stake of 59,875 shares — an estimated $3.76M sold.

Jain Global first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $3.76M in Q1 2026. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Jain Global reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Jain Global sold 59,875 DexCom shares in Q2 2026, an estimated $3.76M.
Jain Global first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
Jain Global's DexCom position peaked at $3.76M in Q1 2026.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.